Glioblastoma Clinical Trials in Milan
9 recruitingMilan, Italy
Showing 1–9 of 9 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Phase 3
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
First Progression of Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC411 enrolled43 locationsNCT05904119
Recruiting
Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach
GlioblastomaGlioblastoma (GBM)Glioblastoma - Category+1 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta30 enrolled1 locationNCT07420543
Recruiting
Not Applicable
Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
GlioblastomaIDH Wild-type and STAT3-positive Glioblastoma
Istituto Oncologico Veneto IRCCS110 enrolled16 locationsNCT06964815
Recruiting
Phase 2
Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma
Glioblastoma, IDH-wildtypeMetforminMalignancies
University of Milano Bicocca25 enrolled1 locationNCT05929495
Recruiting
Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Pancreatic CancerGastric CancerLung Cancer+15 more
Apollomics Inc.497 enrolled35 locationsNCT03175224
Recruiting
Phase 1
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours
Advanced Solid TumorMetastatic CancerGlioblastoma Multiforme+1 more
Phost'In Therapeutics149 enrolled4 locationsNCT05495295
Recruiting
Phase 1Phase 2
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Glioblastoma
Philogen S.p.A.142 enrolled15 locationsNCT04573192
Recruiting
Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness
GlioblastomaGliomaGlioma Glioblastoma Multiforme
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico400 enrolled1 locationNCT06348693